FGFRL1 and lung cancer: In lung cancer, it has been demonstrated that CSC-derived exosomes can enhance the invasive and pro-metastatic properties of lung cancer cells by transferring miR-210-3p that binds and down-modulates fibroblast growth factor receptor-like 1 (FGFRL1), inducing a mesenchymal phenotype (74).